Barclays’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-47,400
Closed -$2.78M 4936
2023
Q1
$2.78M Buy
+47,400
New +$2.61M ﹤0.01% 1943
2020
Q1
Sell
-70,000
Closed -$5.72M 6368
2019
Q4
$5.72M Buy
+70,000
New +$5.37M ﹤0.01% 1868

Other funds holding OMCL

Barclays's OMCL Position: Q1 2026 in Review

Barclays reduced its Omnicell (OMCL) stake by 65% in Q1 2026, selling an estimated $2.65M and leaving 33,556 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2692.

Barclays first reported a position in OMCL in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.3M in Q4 2021. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.

  • Barclays held 33,556 shares of Omnicell worth $1.12M as of Q1 2026.
  • Barclays sold 63,307 Omnicell shares in Q1 2026, an estimated $2.65M.
  • Omnicell made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2692 holding.
  • Barclays first reported a position in Omnicell in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Omnicell position peaked at $21.3M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.